Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis

This publication has 45 references indexed in Scilit:

• Targeting TGF-β signaling for the treatment of fibrosis
  Matrix Biology, 2018
• The unique structural and functional features of CXCL12
  Cellular & Molecular Immunology, 2017
• Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes
  Pharmaceutical Biology, 2016
• Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
  British Journal of Pharmacology, 2015
• Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
  Free Radical Biology and Medicine, 2010
• Expression Analysis of Angiogenic Growth Factors and Biological Axis CXCL12/CXCR4 Axis in Idiopathic Pulmonary Fibrosis
  Connective Tissue Research, 2010
• Relating protein pharmacology by ligand chemistry
  Nature Biotechnology, 2007
• Flavokawain A, a Novel Chalcone from Kava Extract, Induces Apoptosis in Bladder Cancer Cells by Involvement of Bax Protein-Dependent and Mitochondria-Dependent Apoptotic Pathway and Suppresses Tumor Growth in Mice
  Cancer Research, 2005
• Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses
  Phytochemistry, 2002
• Inhibin and Activin Modulate Human Monocyte Chemotaxis and Human Lymphocyte Interferon-γ Production*
  The Journal of Clinical Endocrinology & Metabolism, 1991